Caricamento...
In vivo hyperspectral imaging of microvessel response to trastuzumab treatment in breast cancer xenografts
HER2-amplified (HER2 + ) breast cancers are treated with the anti-HER2 monoclonal antibody trastuzumab. Although trastuzumab reduces production of the angiogenic factor VEGF in HER2 + tumors, the acute and sustained effects of trastuzumab on the tumor vasculature are not understood fully, particular...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Optical Society of America
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4102362/ https://ncbi.nlm.nih.gov/pubmed/25071962 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1364/BOE.5.002247 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|